Actinomycetes are a group of bacteria with a wide variety of human uses, but they are best known for producing natural products, also known as specialised metabolites, such as antibiotics. These microorganisms also produce many antifungals and immunosuppressants, among others. Not only are they important for use in human health and veterinary practices, their natural products are also useful in agriculture. Actinomycetes are found in a wide range of habitats including soils and marine waters, and in association with plant roots and insects. These microorganisms rarely exist in single species communities. As a result, actinomycetes may use their range of chemical products to interact with other bacteria in their communities.
A wide variety of gene clusters have been observed in the genomes of these microbes that would theoretically allow them to produce products that have not been seen in typical lab settings, the majority of which are unknown to us. Usually, in the laboratory these bacteria are studied one species at a time under strictly controlled conditions. These conditions are radically different to those found in natural settings. Dr Traxler and his colleagues see this as a gap in the study of such microbes – by using traditional means we have been ignoring the importance of their interactions with the other microbes in the communities to which they belong.
The ability to ‘see’ molecules produced by individual bacterial cells will open an exciting new window onto microbial life
This was highlighted in a major study in which Dr Traxler and his colleagues found that the well-studied actinomycete, Streptomyces coelicolor, could produce an astounding array of compounds, but only when it interacted with other soil microbes. When studied in interactions with five other actinomycetes, S. coelicolor produced metabolites specific to each of the five other species which it does not produce in isolation. These findings suggest that interactions between microbes may be a rich new source for discovering useful natural products. These metabolites were only observed in specific combinations of species, suggesting that microbes in-situ could produce chemicals we have never seen in the lab. Since then, Dr Traxler has been working to develop an improved method of mass spectrometry imaging that will allow us to study microbes in situ, that is, in the soil, tissues or plant roots where they are naturally found.
A closer look
Dr Traxler and his colleagues have brought together an interdisciplinary approach to this issue, combining mass spectrometry, microbial ecology and microscopy, amongst others, to develop an improved methodology of High Resolution Mass Spectrometry (HR-MSI) that will allow them to study microbes at an ecologically relevant scale. In September 2016, the National Science Foundation (NSF) awarded Dr Traxler a research grant of nearly $300,000 to fund the ongoing development of this new technology.
Matrix assisted laser desorption/ionisation time-of-flight (MALDI-TOF) mass spectrometry imaging (MSI) is a method that enables researchers to visualise the distribution of chemical compounds in a biological sample. In this method, a laser is used to ionise molecules from the sample surface. Moving the laser in a grid pattern allows researchers to create a profile of chemicals from each point across the sample. This information is then used to build images depicting the distribution of individual chemical species.
It is thought that most microbes outside of a lab are found in colonies of less than 100 cells, each of which are around one to five microns in size. A team of researchers in Dr Traxler’s lab, including postdoctoral fellow Rita Pessotti, are working to refine the resolution of their MALDI-TOF apparatus from 10×10 microns to around three microns. This improved resolution will allow single bacterial cells and the chemicals they produce to be studied, not in a large lab culture, but in the plant tissues, soils and even samples from the gastrointestinal tracts of mammals where they would normally occur.
Other improvements are also being made to the methods used in this research, including the optimisation of biological sample preparation techniques to maximise the spatial resolution achieved by MSI. These improvements, once firmly established, will form the basis of a set of protocols that other researchers will be able to use when studying microbes in this way in the future. The ability to ‘see’ molecules produced by individual bacterial cells will open an exciting new window onto microbial life. This will advance our understanding of basic biological mechanisms and principles that govern the exchange of metabolites at the scale of single microbes in their microbiomes – the communities and environments in which they are found. The ultimate aim of this work in the Traxler laboratory is to make the potentially transformative power of micro-scale HR-MSI feasible for any laboratory with an existing high-resolution mass spectrometer.
The future holds an exciting merger between the study of microbial interactions, chemistry, and microbiome function
Changing the future of Microbiology
The Traxler laboratory studies microbial interactions, with an emphasis on understanding how these interactions are mediated by natural products like antibiotics. Dr Traxler’s lab group is an interdisciplinary team, including researchers with expertise in microbial genetics, ecology, natural products chemistry, and informatics analysis. They see that the future holds an exciting merger between the study of microbial interactions, chemistry, and microbiome function.
Dr Traxler seeks to learn why bacteria make compounds like antibiotics. He hopes that, by answering this question, new methods of compound discovery could be formed, helping scientists and doctors design new treatments to minimise the spread of antibiotic resistant pathogens.
Though centred on actinomycetes, the lessons learned from the work of Dr Traxler and his research team could be applied to countless other antibiotic-producing microbes. With an ever-increasing number of antibiotic resistant pathogens, this innovative research could provide new sources of antibiotics with the potential to save numerous lives that would otherwise have gone unnoticed.
Other than the discovery of new antibiotics, what benefits do you think will come of studying microbes at this level?
Why is it important to understand the reasons bacteria make compounds like antibiotics?
Why have these interaction-specific metabolites taken so long to find?
Beyond this, I would say that discovering natural products from microbes in pure culture yielded an incredible bounty of therapeutics that sustained us for many decades. As discovering novel compounds has become more challenging, we must innovate, and looking at microbial interactions is one way we can do that.
Where would you like to take this research next?
Do you think students at Berkeley benefit from involving this research in their classes?